AU2001248365A1 - 2-(arylalkylamino)pyrimidone derivatives and 2-(heteroarylalkylamino)pyrimidone derivatives - Google Patents
2-(arylalkylamino)pyrimidone derivatives and 2-(heteroarylalkylamino)pyrimidone derivativesInfo
- Publication number
- AU2001248365A1 AU2001248365A1 AU2001248365A AU4836501A AU2001248365A1 AU 2001248365 A1 AU2001248365 A1 AU 2001248365A1 AU 2001248365 A AU2001248365 A AU 2001248365A AU 4836501 A AU4836501 A AU 4836501A AU 2001248365 A1 AU2001248365 A1 AU 2001248365A1
- Authority
- AU
- Australia
- Prior art keywords
- pyrimidone derivatives
- heteroarylalkylamino
- arylalkylamino
- pyrimidone
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00400804A EP1136484A1 (fr) | 2000-03-23 | 2000-03-23 | Dérivés de 2-(arylalkylamino)pyrimidine |
| EP00400806A EP1136491A1 (fr) | 2000-03-23 | 2000-03-23 | Dérivés de 2-[(hétéroaryl)alkylamino]pyrimidinones |
| EP00400804 | 2000-03-23 | ||
| JP2000081938A JP2001270884A (ja) | 2000-03-23 | 2000-03-23 | ピリミドン誘導体 |
| EP00400805A EP1136099A1 (fr) | 2000-03-23 | 2000-03-23 | Dérivés de 2-(indolylalkylamino)pyridone comme inhibiteurs de GSK3bêta |
| JP2000-81938 | 2000-03-23 | ||
| EP00400805 | 2000-03-23 | ||
| EP00400806 | 2000-03-23 | ||
| PCT/EP2001/003638 WO2001070727A1 (fr) | 2000-03-23 | 2001-03-22 | Derives de 2-(arylalkylamino)pyrimidone et derives de 2-(heteroarylalkylamino)pyrimidone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001248365A1 true AU2001248365A1 (en) | 2001-10-03 |
Family
ID=27440051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001248365A Abandoned AU2001248365A1 (en) | 2000-03-23 | 2001-03-22 | 2-(arylalkylamino)pyrimidone derivatives and 2-(heteroarylalkylamino)pyrimidone derivatives |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR028281A1 (fr) |
| AU (1) | AU2001248365A1 (fr) |
| WO (1) | WO2001070727A1 (fr) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE284712T1 (de) | 2000-04-26 | 2005-01-15 | Eisai Co Ltd | Medizinische zusammensetzungen zur förderung der aktivierung der eingeweide |
| TWI335221B (en) * | 2001-09-27 | 2011-01-01 | Alcon Inc | Inhibtors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| TWI330183B (fr) | 2001-10-22 | 2010-09-11 | Eisai R&D Man Co Ltd | |
| TWI301834B (en) * | 2001-10-22 | 2008-10-11 | Eisai R&D Man Co Ltd | Pyrimidone compound and pharmaceutical composition including the same |
| JP2005525362A (ja) * | 2002-03-01 | 2005-08-25 | カイロン コーポレイション | 虚血の処置のための方法および組成物 |
| WO2003092584A2 (fr) | 2002-04-30 | 2003-11-13 | Alcon, Inc. | Agents regulant, inhibant ou modulant l'activite et/ou l'expression du facteur de croissance du tissu conjonctif (ctgf) utilises comme moyen unique pour reduire la pression intraoculaire et traiter les retinopathies glaucomateuses/neuropathies optiques |
| EP1925306A3 (fr) * | 2002-04-30 | 2008-09-17 | Alcon, Inc. | Agents regulant, inhibant ou modulant l'activite et/ou l'expression du facteur de croissance du tissu conjonctif (ctgf) pour reduire la pression intraoculaire |
| TW200413320A (en) | 2002-10-21 | 2004-08-01 | Chiron Corp | Carbocycle based inhibitors of glycogen synthase kinase 3 |
| JP2007520558A (ja) * | 2004-02-04 | 2007-07-26 | スミスクライン・ビーチャム・コーポレイション | キナーゼ阻害剤として有用なピリミジノン化合物 |
| JP2008535779A (ja) | 2005-01-07 | 2008-09-04 | エモリー・ユニバーシテイ | Ｈｉｖ感染治療のためのｃｘｃｒ４拮抗薬 |
| EP2258359A3 (fr) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenèse par modulation des récepteurs muscariniques avec sabcomeline |
| EP1928437A2 (fr) | 2005-08-26 | 2008-06-11 | Braincells, Inc. | Neurogenese par modulation du recepteur muscarinique |
| CA2625153A1 (fr) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation de la neurogenese par inhibition de la pde |
| AU2006308889A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | GABA receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| WO2008008854A2 (fr) | 2006-07-11 | 2008-01-17 | Emory University | Antagonistes de cxcr4 comprenant des structures de diazine et de triazine pour le traitement de troubles médicaux |
| NZ574619A (en) | 2006-07-18 | 2012-03-30 | Univ Rochester | THIADIAZOLIDINEDIONE DERIVATIVES including 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8) |
| WO2008023239A1 (fr) * | 2006-08-23 | 2008-02-28 | Pfizer Products Inc. | Composés de pyrimidone en tant qu'inhibiteurs de gsk-3 |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| AR070950A1 (es) * | 2007-11-01 | 2010-05-19 | Acucela Inc | Compuestos derivados de amina, composiciones farmaceuticas de ellos, compuestos inhibidores de produccion de 11-cis-retinol y metodos para tratar enfermedades y trastornos oftalmicos |
| US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW520362B (en) * | 1996-12-05 | 2003-02-11 | Amgen Inc | Substituted pyrimidine compounds and pharmaceutical composition comprising same |
-
2001
- 2001-03-22 WO PCT/EP2001/003638 patent/WO2001070727A1/fr not_active Application Discontinuation
- 2001-03-22 AU AU2001248365A patent/AU2001248365A1/en not_active Abandoned
- 2001-03-23 AR ARP010101373A patent/AR028281A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR028281A1 (es) | 2003-04-30 |
| WO2001070727A1 (fr) | 2001-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001248365A1 (en) | 2-(arylalkylamino)pyrimidone derivatives and 2-(heteroarylalkylamino)pyrimidone derivatives | |
| AU2002226486A1 (en) | Novel c-glycoside derivatives and use thereof | |
| AU2001266583A1 (en) | Epothilone derivatives and methods for making and using the same | |
| AU2002235128A1 (en) | Expression miniarrays and uses thereof | |
| AU2002226487A1 (en) | Novel c-glycoside derivatives and use thereof | |
| AU2001277754A1 (en) | Proline derivatives and use thereof as drugs | |
| AU2002225356A1 (en) | Glucopyranosyloxypyrazole derivatives and use thereof in medicines | |
| AU2001230338A1 (en) | Isothiazole derivatives and their use as pesticides | |
| AU2001281850A1 (en) | Use of inulin and inulin derivatives | |
| AU2001269175A1 (en) | Diamino phenothiazine derivatives and composition comprising same | |
| AU6124999A (en) | Hydrazinooxoacetamide derivatives and insecticide | |
| AU2001292936A1 (en) | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines | |
| AU2001228667A1 (en) | Isothiazole derivatives and their use as pesticides | |
| AU2001248820A1 (en) | Thiazole and oxazole derivatives | |
| AU2001262149A1 (en) | 2-(indanylamino)pyrimidone and 2-(tetrahydronaphthalenylamino)pyrimidone derivatives | |
| AU7271600A (en) | Quinazolinone and azaquinazolinone derivatives | |
| AU2002308891A1 (en) | Novel heterocyclic derivatives and medicinal use thereof | |
| AU2001230355A1 (en) | Benzoxazole derivatives and their use as pesticides | |
| AU2001230358A1 (en) | Isothiazole derivatives and their use as pesticides | |
| AU2001295185A1 (en) | Multiplexing-interleaving and demultiplexing-deinterleaving | |
| AU2002216650A1 (en) | Triazine derivatives as lpaat-b inhibitors and uses thereof | |
| AU2001229439A1 (en) | Bioconjugates and uses thereof | |
| AU2001261375A1 (en) | Human caspase-12 materials and methods | |
| AU2002219176A1 (en) | Dihydroindole and tetrahydroquinoline derivatives | |
| AU2002338989A1 (en) | Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine derivatives |